{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:02:16Z","timestamp":1789758136812,"version":"4.0.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007737","name":"St Jude Children's Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ymthe.2024.07.022","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T22:11:36Z","timestamp":1722377496000},"page":"3433-3452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Varun","family":"Katta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiera","family":"O\u2019Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiyagaraj","family":"Mayuranathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cicera R.","family":"Lazzarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael K.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalin","family":"Mayberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garret","family":"Manquen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonjeong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikitha","family":"Nimmagadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin A.","family":"Dempsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GaHyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Lockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Meagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Tisdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9161-3993","authenticated-orcid":false,"given":"Shengdar Q.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.07.022_bib1","first-page":"305","article-title":"Sickle cell disease","volume":"377","author":"Piel","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.07.022_bib2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/178792a0","article-title":"A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin","volume":"178","author":"Ingram","year":"1956","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.07.022_bib3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.07.022_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2024.07.022_bib5","article-title":"Recent advances in sickle-cell disease therapies: A review of voxelotor, crizanlizumab, and L-glutamine","volume":"10","author":"Migotsky","year":"2022","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.ymthe.2024.07.022_bib6","first-page":"100","article-title":"Barriers to bone marrow transplantation for sickle cell anemia","volume":"2","author":"Walters","year":"1996","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.ymthe.2024.07.022_bib7","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(19)30154-1","article-title":"Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study","volume":"6","author":"Eapen","year":"2019","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.ymthe.2024.07.022_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146394","article-title":"Genetic therapies for the first molecular disease","volume":"131","author":"Doerfler","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.07.022_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajh.26741","article-title":"Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study","volume":"98","author":"Kanter","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymthe.2024.07.022_bib10","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.07.022_bib11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41467-021-20909-x","article-title":"Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice","volume":"12","author":"Wilkinson","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.07.022_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","article-title":"Base editing of haematopoietic stem cells rescues sickle cell disease in mice","volume":"595","author":"Newby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.07.022_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2022-162353","article-title":"Efficacy and safety of a single dose of exagamglogene autotemcel for severe sickle cell disease","volume":"140","author":"Frangoul","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.07.022_bib14","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.ymthe.2021.03.010","article-title":"A pause in gene therapy: Reflecting on the unique challenges of sickle cell disease","volume":"29","author":"Leonard","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.07.022_bib15","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood.2019000949","article-title":"Lentiviral and genome-editing strategies for the treatment of \u03b2-hemoglobinopathies","volume":"134","author":"Magrin","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.07.022_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/jcm10030482","article-title":"Genome editing for \u03b2-hemoglobinopathies: Advances and challenges","volume":"10","author":"Frati","year":"2021","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.ymthe.2024.07.022_bib17","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ymthe.2019.05.014","article-title":"Editing the sickle cell disease mutation in human hematopoietic stem cells: Comparison of endonucleases and homologous donor templates","volume":"27","author":"Romero","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.07.022_bib18","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.stem.2022.09.001","article-title":"Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells","volume":"29","author":"Ferrari","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2024.07.022_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41587-023-01915-4","article-title":"Genotoxic effects of base and prime editing in human hematopoietic stem cells","volume":"42","author":"Fiumara","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.07.022_bib20","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood.2020007645","article-title":"Fetal hemoglobin in sickle cell anemia","volume":"136","author":"Steinberg","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.07.022_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2141.2010.08105.x","article-title":"Advances in the understanding of haemoglobin switching","volume":"149","author":"Sankaran","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2024.07.022_bib22","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/S0140-6736(15)01341-0","article-title":"Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies","volume":"387","author":"Lettre","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.07.022_bib23","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1182\/blood-2017-02-765891","article-title":"Treating sickle cell disease by targeting HbS polymerization","volume":"129","author":"Eaton","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.07.022_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.1958.tb03844.x","article-title":"Hereditary persistence of foetal haemoglobin production, and its interaction with the sickle-cell trait","volume":"4","author":"Jacob","year":"1958","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2024.07.022_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.1998.tb10460.x","article-title":"Molecular basis of hereditary persistence of fetal hemoglobin","volume":"850","author":"Forget","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ymthe.2024.07.022_bib26","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.tig.2022.07.003","article-title":"Effective therapies for sickle cell disease: are we there yet?","volume":"38","author":"Crossley","year":"2022","journal-title":"Trends Genet."},{"key":"10.1016\/j.ymthe.2024.07.022_bib27","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1126\/science.1165409","article-title":"Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A","volume":"322","author":"Sankaran","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.07.022_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.aad3312","article-title":"Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin","volume":"351","author":"Masuda","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.07.022_bib29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature15521","article-title":"BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis","volume":"527","author":"Canver","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.07.022_bib30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm.4170","article-title":"A genome-editing strategy to treat \u03b2-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition","volume":"22","author":"Traxler","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.07.022_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay9392","article-title":"Editing a \u03b3-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype","volume":"6","author":"Weber","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2024.07.022_bib32","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/S2666-6367(21)00101-9","volume":"27","author":"Soni","year":"2021","journal-title":"Transplant. Cell Ther."},{"key":"10.1016\/j.ymthe.2024.07.022_bib33","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s41591-022-01906-z","article-title":"CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric \u03b20\/\u03b20 transfusion-dependent \u03b2-thalassemia","volume":"28","author":"Fu","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.07.022_bib34","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/bloodadvances.2019000820","article-title":"Genome editing of HBG1 and HBG2 to induce fetal hemoglobin","volume":"3","author":"M\u00e9tais","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2024.07.022_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood-2018-99-114780","volume":"132","author":"Chang","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.07.022_bib36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.HS9.0000564332.87522.af","article-title":"Ps1518 genome editing of hbg1\/2 promoter leads to robust hbf induction in\u00a0vivo, while editing of bcl11a erythroid enhancer results in erythroid defects","volume":"3","author":"Heath","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.ymthe.2024.07.022_bib37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.tig.2018.09.004","article-title":"Wake-up Sleepy Gene: Reactivating Fetal Globin for \u03b2-Hemoglobinopathies","volume":"34","author":"Wienert","year":"2018","journal-title":"Trends Genet."},{"key":"10.1016\/j.ymthe.2024.07.022_bib38","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.07.022_bib39","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41591-019-0401-y","article-title":"Highly efficient therapeutic gene editing of human hematopoietic stem cells","volume":"25","author":"Wu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.07.022_bib40","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1182\/blood-2010-11-321414","article-title":"Macrophages prevent human red blood cell reconstitution in immunodeficient mice","volume":"118","author":"Hu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.07.022_bib41","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.ymthe.2023.03.007","article-title":"An optimized SpCas9 high-fidelity variant for direct protein delivery","volume":"31","author":"Pedrazzoli","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.07.022_bib42","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood.V63.4.921.921","article-title":"Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?","volume":"63","author":"Powars","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.07.022_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood-2013-09-528067","article-title":"Fetal hemoglobin in sickle cell anemia: a glass half full?","volume":"123","author":"Steinberg","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.07.022_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2011-03-325258","article-title":"Fetal hemoglobin in sickle cell anemia","volume":"118","author":"Akinsheye","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.07.022_bib45","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1203\/00006450-199804000-00011","article-title":"Quantitative correlation between globin mRNAs and synthesis of fetal and adult hemoglobins during hemoglobin switchover in the perinatal period","volume":"43","author":"Peri","year":"1998","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymthe.2024.07.022_bib46","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.07.022_bib47","doi-asserted-by":"crossref","first-page":"12868","DOI":"10.1073\/pnas.1915085117","article-title":"Putative regulators for the continuum of erythroid differentiation revealed by single-cell transcriptome of human BM and UCB cells","volume":"117","author":"Huang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.07.022_bib48","series-title":"Disorders of\u00a0Hemoglobin: Genetics, Pathophysiology, Clinical Management","author":"Steinberg","year":"2009"},{"key":"10.1016\/j.ymthe.2024.07.022_bib49","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.07.022_bib50","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.07.022_bib51","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1021\/acscentsci.3c00289","article-title":"Spacer fidelity assessments\u00a0of guide RNA by top-down mass spectrometry","volume":"9","author":"Macias","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ymthe.2024.07.022_bib52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.xphs.2019.10.003","article-title":"Immunogenicity of Cas9 Protein","volume":"109","author":"Mehta","year":"2020","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ymthe.2024.07.022_bib53","author":"Center for Biologics Evaluation and Research"},{"key":"10.1016\/j.ymthe.2024.07.022_bib54","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41588-021-00904-0","article-title":"Activation of \u03b3-globin gene expression by GATA1 and NF-Y in hereditary persistence of fetal hemoglobin","volume":"53","author":"Doerfler","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.07.022_bib55","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41587-020-0555-7","article-title":"CHANGE-seq reveals genetic and epigenetic effects on CRISPR\u2013Cas9 genome-wide activity","volume":"38","author":"Lazzarotto","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.07.022_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41588-022-01257-y","article-title":"Human genetic diversity alters off-target outcomes of therapeutic gene editing","volume":"55","author":"Cancellieri","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.07.022_bib57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/crispr.2020.0036","article-title":"CALITAS: A CRISPR-Cas-aware ALigner for In silico off-TArget Search","volume":"4","author":"Fennell","year":"2021","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2024.07.022_bib58","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12864-018-4561-9","article-title":"UDiTaS\u2122, a genome editing detection method for indels and genome rearrangements","volume":"19","author":"Giannoukos","year":"2018","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ymthe.2024.07.022_bib59","series-title":"Infercnv (Bioconductor)","author":"Tickle","year":"2019"},{"key":"10.1016\/j.ymthe.2024.07.022_bib60","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","article-title":"Exagamglogene Autotemcel for Severe Sickle Cell Disease","volume":"390","author":"Frangoul","year":"2024","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.07.022_bib61","article-title":"Gene editing without ex\u00a0vivo culture evades genotoxicity in human hematopoietic stem cells","author":"Zeng","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2024.07.022_bib62","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa2215643","article-title":"CRISPR-Cas9 editing of the HBG1 and HBG2 promoters to treat sickle cell disease","volume":"389","author":"Sharma","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.07.022_bib63","first-page":"2669","article-title":"Discontinued CRISPR gene therapy for sickle-cell disease improves symptoms","volume":"29","author":"Carvalho","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.07.022_bib64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.07.022_bib65","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/s41588-023-01434-7","article-title":"Potent and uniform fetal hemoglobin induction via base editing","volume":"55","author":"Mayuranathan","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.07.022_bib66","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41588-021-00834-x","article-title":"Author Correction: Transcription factor competition at the \u03b3-globin promoters controls hemoglobin switching","volume":"53","author":"Liu","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.07.022_bib67","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/s41587-022-01377-0","article-title":"Frequent aneuploidy in primary human T\u00a0cells after CRISPR-Cas9 cleavage","volume":"40","author":"Nahmad","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.07.022_bib68","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1016\/j.cell.2023.08.041","article-title":"Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T\u00a0cells","volume":"186","author":"Tsuchida","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.07.022_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2024.101185","article-title":"Revolutionising healing: Gene Editing\u2019s breakthrough against sickle cell disease","volume":"65","author":"Dimitrievska","year":"2024","journal-title":"Blood Rev."},{"key":"10.1016\/j.ymthe.2024.07.022_bib70","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1038\/s41467-022-34493-1","article-title":"Base-editing-mediated dissection of a \u03b3-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression","volume":"13","author":"Antoniou","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.07.022_bib71","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.stem.2023.10.007","article-title":"Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs","volume":"30","author":"Han","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2024.07.022_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41467-022-35508-7","article-title":"Therapeutic adenine base editing of human hematopoietic stem cells","volume":"14","author":"Liao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.07.022_bib73","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41591-020-0790-y","article-title":"Therapeutic base editing of human hematopoietic stem cells","volume":"26","author":"Zeng","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.07.022_bib74","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.3324\/haematol.2019.236182","article-title":"Safe and efficient peripheral blood\u00a0stem cell collection in patients with sickle cell disease using plerixafor","volume":"105","author":"Uchida","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.ymthe.2024.07.022_bib75","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/bjh.18311","article-title":"Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease","volume":"198","author":"Sharma","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2024.07.022_bib76","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2024.07.022_bib77","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","article-title":"FLASH: fast length adjustment of short reads to improve genome assemblies","volume":"27","author":"Mago\u010d","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2024.07.022_bib78","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2024.07.022_bib79","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624004775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624004775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T12:48:57Z","timestamp":1758199737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624004775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":79,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1525001624004775"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.07.022","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.04.30.591737","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}